UPC Stock Analysis: Buy, Sell, or Hold?
UPC - Universe Pharmaceuticals Inc. Ordinary Shares
$6.32
0.76 (13.67%)
▲
5d:
+122.54%
30d:
+86.95%
90d:
+131.5%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Apr 22, 2026
0d
Get Alerted When UPC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: UPC is 11.3% above its trading range ($5.68). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: UPC is 11.3% above its trading range ($5.68). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: UPC is currently trading at $6.32, which is considered extended relative to its 30-day fair value range of $1.90 to $5.68.
Technical Outlook: Technically, UPC is in a downtrend. The price is approaching resistance at $3.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 13.7% recently.
Market Sentiment: UPC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UPC is in a downtrend. The price is approaching resistance at $3.70. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 13.7% recently.
Market Sentiment: UPC has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.90 -
$5.68
Company Quality Score
58/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.1%
All Signals
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Strong upward momentum (+13.7%)
Trading Range Analysis
30-Day Trading Range
$1.90 -
$5.68
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.62
Resistance Level
$3.70
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Revenue Growth (YoY)
-14.1%
Earnings Growth (YoY)
-82.0%
Profit Margin
-20.6%
Share & Embed Analysis
Last updated: July 03, 2026 1:40 AM ET
Data refreshes hourly during market hours. Next update: 2:40 AM
Data refreshes hourly during market hours. Next update: 2:40 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UPC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 62 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 63 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 54 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 60 HOLD |
